FDA approves Telix brain cancer imaging drug Pixclara
September 14, 2026 | 15:32
The US Food and Drug Administration approved Telix Pharmaceuticals' New Drug Application for Pixclara to advance imaging procedures in adult and paediatric brain cancer patients.
Mobile Version